These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9884117)

  • 1. Tolerance to acute anxiolysis but no withdrawal anxiogenesis in mice treated chronically with 5-HT1A receptor antagonist, WAY 100635.
    Cao BJ; Rodgers RJ
    Neurosci Biobehav Rev; 1998; 23(2):247-57. PubMed ID: 9884117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
    Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK; Heaton M; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190.
    Cao BJ; Rodgers RJ
    Pharmacol Biochem Behav; 1997 Oct; 58(2):593-603. PubMed ID: 9300624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
    Kennett GA; Trail B; Bright F
    Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-HT1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat.
    Stanhope KJ; Dourish CT
    Psychopharmacology (Berl); 1996 Dec; 128(3):293-303. PubMed ID: 8972549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze.
    Sakaue M; Ago Y; Sowa C; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2003 Jan; 458(1-2):141-4. PubMed ID: 12498918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.
    Cheeta S; Irvine EE; Kenny PJ; File SE
    Psychopharmacology (Berl); 2001 Apr; 155(1):78-85. PubMed ID: 11374339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice.
    Cao BJ; Rodgers RJ
    Psychopharmacology (Berl); 1998 Oct; 139(3):185-94. PubMed ID: 9784072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
    Xu L; Anwyl R; De Vry J; Rowan MJ
    Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
    Holmes A; Iles JP; Mayell SJ; Rodgers RJ
    Behav Brain Res; 2001 Aug; 122(2):159-67. PubMed ID: 11334646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
    Strauss CV; Vicente MA; Zangrossi H
    Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.
    Rodgers RJ; Cole JC
    Eur J Pharmacol; 1994 Aug; 261(3):321-5. PubMed ID: 7813555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors.
    Ghisleni G; Kazlauckas V; Both FL; Pagnussat N; Mioranzza S; Rocha JB; Souza DO; Porciúncula LO
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1508-15. PubMed ID: 18579279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.